Young CW - Search Results

1

Clinical pharmacology of deoxyspergualin in patients with advanced cancer.

Muindi JF, Lee SJ, Baltzer L, Jakubowski A, Scher HI, Sprancmanis LA, Riley CM, Vander Velde D, Young CW. Muindi JF, et al. Among authors: young cw. Cancer Res. 1991 Jun 15;51(12):3096-101. Cancer Res. 1991. PMID: 2039989 Clinical Trial.

2

Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.

Young CW, Fanucchi MP, Declan Walsh T, Baltzer L, Yaldaei S, Stevens YW, Gordon C, Tong W, Rifkind RA, Marks PA. Young CW, et al. Cancer Res. 1988 Dec 15;48(24 Pt 1):7304-9. Cancer Res. 1988. PMID: 3191501

3

Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer.

Muindi JF, Scher HI, Rigas JR, Warrell RP Jr, Young CW. Muindi JF, et al. Among authors: young cw. Cancer Res. 1994 Apr 15;54(8):2125-8. Cancer Res. 1994. PMID: 8174117

4

Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans-retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms.

Muindi JF, Young CW. Muindi JF, et al. Among authors: young cw. Cancer Res. 1993 Mar 15;53(6):1226-9. Cancer Res. 1993. PMID: 8383004

5

Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.

Kris MG, Kinahan JJ, Gralla RJ, Fanucchi MP, Wertheim MS, O'Connell JP, Marks LD, Williams L, Farag F, Young CW, et al. Kris MG, et al. Among authors: young cw. Cancer Res. 1988 Oct 1;48(19):5573-9. Cancer Res. 1988. PMID: 3416310 Clinical Trial.

6

In vitro differential metabolism of merbarone by xanthine oxidase and microsomal flavoenzymes. The role of reactive oxygen species.

Muindi JF, Stevens YW, Warrell RP Jr, Young CW. Muindi JF, et al. Among authors: young cw. Drug Metab Dispos. 1993 May-Jun;21(3):410-4. Drug Metab Dispos. 1993. PMID: 8100495

7

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.

Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr. Muindi J, et al. Among authors: young cw. Blood. 1992 Jan 15;79(2):299-303. Blood. 1992. PMID: 1309668 Free article.

8

Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.

Muindi JR, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW, Warrell RP Jr. Muindi JR, et al. Among authors: young cw. Cancer Res. 1992 Apr 15;52(8):2138-42. Cancer Res. 1992. PMID: 1559217

9

Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).

Kelsen DP, Scher H, Alcock N, Leyland-Jones B, Donner A, Williams L, Greene G, Burchenal JH, Tan C, Philips FS, Young CW. Kelsen DP, et al. Among authors: young cw. Cancer Res. 1982 Nov;42(11):4831-5. Cancer Res. 1982. PMID: 7127319

10

Induction of profound hypouricemia by a non-sedating thiobarbiturate.

Warrell RP Jr, Muindi J, Stevens YW, Isaacs M, Young CW. Warrell RP Jr, et al. Among authors: young cw. Metabolism. 1989 Jun;38(6):550-4. doi: 10.1016/0026-0495(89)90215-1. Metabolism. 1989. PMID: 2725294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters